State Street SPDR S&P Biotech ETF (XBI) Stock Analysis
A live, multi-source view of State Street SPDR S&P Biotech ETF (XBI): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About State Street SPDR S&P Biotech ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Key statistics · as of 2026-09-06
As of 2026-09-06, State Street SPDR S&P Biotech ETF (XBI); the shares traded in a 52-week range of $92.64 – $169.89.
- 52-week range
- $92.64 – $169.89
- Average volume
- 8.9M
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, State Street SPDR S&P Biotech ETF (XBI) last closed at $156.82 (the last completed close before that scan).
Technicals at the scan: RSI 43 (neutral territory), price -3.9% versus its 20-day average, 20-day versus 50-day average spread +3.1%, MACD histogram -1.24.
Sentiment inputs: 67% of recent Finnhub-scored headlines read bullish; StockTwits 40% bullish.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 2 buys and 0 sells of XBI; corporate insiders filed 0 buys and 0 sells (1 filer, latest disclosure 2026-08-05). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Tommy Tuberville (2B/0S). Who is trading what
RapidTradeView pick record
XBI has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls State Street SPDR S&P Biotech ETF (XBI) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell XBI.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.